X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19) 19
index medicus (19) 19
mela5 (19) 19
female (18) 18
middle aged (18) 18
aged (17) 17
oncology (17) 17
male (16) 16
melanoma - drug therapy (16) 16
original reports (16) 16
adult (14) 14
melanoma - pathology (10) 10
aged, 80 and over (9) 9
skin neoplasms - drug therapy (9) 9
skin neoplasms - pathology (9) 9
treatment outcome (8) 8
antibodies, monoclonal - adverse effects (6) 6
ipilimumab (6) 6
kaplan-meier estimate (6) 6
melanoma - mortality (6) 6
antibodies, monoclonal - therapeutic use (5) 5
antineoplastic agents - therapeutic use (5) 5
drug administration schedule (5) 5
mela7 (5) 5
metastatic melanoma (5) 5
antineoplastic agents - administration & dosage (4) 4
antineoplastic agents - adverse effects (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
disease-free survival (4) 4
mela6 (4) 4
melanoma - immunology (4) 4
survival (4) 4
survival rate (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
dacarbazine (3) 3
diagnosis in oncology (3) 3
double-blind method (3) 3
follow-up studies (3) 3
melanoma - genetics (3) 3
melanoma - secondary (3) 3
neoplasm staging (3) 3
proto-oncogene proteins b-raf - genetics (3) 3
skin neoplasms - genetics (3) 3
to21 (3) 3
vemurafenib (3) 3
adjuvant therapy (2) 2
adolescent (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibody (2) 2
bevacizumab (2) 2
biomarkers, tumor - genetics (2) 2
blockade (2) 2
cancer (2) 2
carboplatin - administration & dosage (2) 2
carcinoma (2) 2
chemotherapy, adjuvant (2) 2
cohort studies (2) 2
combination (2) 2
dacarbazine - administration & dosage (2) 2
dose-response relationship, drug (2) 2
esp (2) 2
fatigue - chemically induced (2) 2
granulocyte-macrophage colony-stimulating factor - administration & dosage (2) 2
improved survival (2) 2
infusions, intravenous (2) 2
interleukin-2 - administration & dosage (2) 2
interleukin-2 - adverse effects (2) 2
mela3 (2) 2
melanoma - surgery (2) 2
metastatic malignant-melanoma (2) 2
mutation (2) 2
niacinamide - analogs & derivatives (2) 2
paclitaxel - administration & dosage (2) 2
prognosis (2) 2
progression (2) 2
prospective studies (2) 2
protein kinase inhibitors - therapeutic use (2) 2
proto-oncogene proteins b-raf - antagonists & inhibitors (2) 2
pyridones - administration & dosage (2) 2
pyridones - adverse effects (2) 2
pyrimidinones - administration & dosage (2) 2
pyrimidinones - adverse effects (2) 2
retrospective studies (2) 2
reverse transcriptase polymerase chain reaction (2) 2
skin neoplasms - mortality (2) 2
skin neoplasms - surgery (2) 2
stage-iv melanoma (2) 2
t-cells (2) 2
timg3 (2) 2
to6 (2) 2
young adult (2) 2
2nd-line therapy (1) 1
acetylcholine-receptor (1) 1
acquired-resistance (1) 1
actinic keratosis (1) 1
administration, oral (1) 1
adrenal cortex hormones - therapeutic use (1) 1
advanced cancers (1) 1
adverse events (1) 1
alopecia - chemically induced (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 5, pp. 616 - 622
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 4, pp. 482 - 489
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2013, Volume 31, Issue 26, pp. 3182 - 3190
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2014, Volume 32, Issue 33, pp. 3697 - 3704
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2012, Volume 30, Issue 3, pp. 316 - 321
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2014, Volume 32, Issue 33, pp. 3771 - 3778
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2011, Volume 29, Issue 9, pp. 1210 - 1215
Journal Article